Statistics

Total Visits

Views
A randomized phase II study of raltitrexed and gefitinib versus raltitrexed alone as second line chemotherapy in patients with colorectal cancer. (1839IL/0143)32

Select a period of time:

Number of views in the range

Views
A randomized phase II study of raltitrexed and gefitinib versus raltitrexed alone as second line chemotherapy in patients with colorectal cancer. (1839IL/0143)21

Views

Views
May 20242
June 20241
July 20243
August 20245
September 20243
October 20245
November 20242
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States16
United Kingdom4
 

Top cities views

Views
Chicago3